Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up - Sundstrøm, S; Bremnes, R M; Kaasa, S (J Clin Oncol, 2002)
, et al; Norwegian Lung Cancer Study Group.